AVRO NASDAQ
AVROBIO, Inc.
1W: -4.8%
1M: +1.4%
3M: +12.0%
1Y: +41.4%
3Y: -85.0%
5Y: -90.4%
$1.40
Last traded 2024-06-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$84M
-44.9% ▼
Net Income
-$74M
-27.9% ▼
EPS (Diluted)
$-4.05
+40.7% ▲
EBITDA
-$71M
-23.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $1M | $4M | $617K | $0 | $0 |
| Gross Profit | -$1M | -$4M | -$617K | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $83M | $72M | $47M | $41M | $63M |
| SG&A Expenses | $36M | $33M | $24M | $17M | $21M |
| Operating Expenses | $119M | $105M | $71M | $58M | $84M |
| Operating Income | -$119M | -$105M | -$72M | -$58M | -$84M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $299K | $2M | -$107K | $63K |
| Income Before Tax | -$119M | -$106M | $13M | -$58M | -$73M |
| Tax Expense | -$1M | $157K | $377K | $0 | -$1M |
| Net Income | -$118M | -$106M | $12M | -$58M | -$74M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-2.75 | $-2.42 | $0.27 | $-6.83 | $-4.05 |
| EBITDA | -$118M | -$104M | -$71M | -$58M | -$71M |
| Shares Outstanding | 43M | 44M | 4M | 8M | 18M |